Michael Lefenfeld is Director of Immunome Inc.. Currently has a direct ownership of 40,747 shares of IMNM, which is worth approximately $448,217. The most recent transaction as insider was on Jan 15, 2023, when has been sold 13,875 shares (Common Stock) at a price of $4.0 per share, resulting in proceeds of $55,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.7K
0% 3M change
0% 12M change
Total Value Held $448,217

Michael Lefenfeld Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 15 2023
BUY
Grant, award, or other acquisition
$55,500 $4.0 p/Share
13,875 Added 25.4%
40,747 Common Stock
May 26 2021
BUY
Open market or private purchase
$25,405 $19.03 p/Share
1,335 Added 4.73%
26,872 Common Stock
May 25 2021
BUY
Open market or private purchase
$50,065 $18.44 p/Share
2,715 Added 9.61%
25,537 Common Stock
May 24 2021
BUY
Open market or private purchase
$10,680 $17.8 p/Share
600 Added 2.56%
22,822 Common Stock
Oct 06 2020
BUY
Conversion of derivative security
-
22,222 Added 50.0%
22,222 Common Stock
ML

Michael Lefenfeld

Director
Exton, PA

Track Institutional and Insider Activities on IMNM

Follow Immunome Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMNM shares.

Notify only if

Insider Trading

Get notified when an Immunome Inc. insider buys or sells IMNM shares.

Notify only if

News

Receive news related to Immunome Inc.

Track Activities on IMNM